NEW YORK, April 23, 2014 /PRNewswire/ --
Today, Analysts Review released its analysts' notes regarding
Costco Wholesale Corporation (NASDAQ: COST), Liberty Media Corp.
(NASDAQ: LMCA), Apollo Education Group Inc. (NASDAQ: APOL), Yum!
Brands Inc. (NYSE: YUM), and Myriad Genetics Inc. (NASDAQ: MYGN).
Private wealth members receive these notes ahead of publication. To
reserve complementary membership, limited openings are available
at: http://www.AnalystsReview.com/register
--
Costco Wholesale Corporation Analyst Notes
Costco Wholesale Corporation (Costco) announced that the Company
will release its monthly sales results for the month of
March 2014 on April 10, 2014. For the four-week reporting month
of February ended March 2, 2014, the
Company reported net sales of $7.90
billion versus $7.58 billion
in the year ago period. Costco, along with its subsidiaries, is
engaged in the operation of membership warehouses in the U.S. and
Puerto Rico, Canada, the U.K., Mexico, Japan, Australia, and through majority owned
subsidiaries in Taiwan and Korea.
The full analyst notes on Costco Wholesale Corporation are
available to download free of charge at:
http://www.AnalystsReview.com/04072014/COST/report.pdf
--
Liberty Media Corp. Analyst Notes
On April 3, 2014, Liberty Media
Corp. (Liberty Media), along with Barnes & Noble Inc. (Barnes
& Noble), announced that Liberty Media has entered into
agreements to reduce its stake in Barnes & Noble -
largest book retailer in the U.S. The Company informed Barnes
& Noble that it has sold the majority of its stake to qualified
institutional buyers in accordance with the Rule 144A under the
Securities Act, but will retain nearly 10% of its initial
investment. The sale of stake is expected to close on April 8, 2014. Concurrently, Liberty Media's
right to elect two preferred stock Directors to the Board of Barnes
& Noble's along with consent rights and pre-emptive rights will
cease on April 8, 2014. As a result,
Greg Maffei will no longer serve the
board as of the closing on April 8,
2014, while Mark Carleton has
been re-elected to the Barnes & Noble
Board, effective April 8,
2014. The full analyst notes on Liberty Media Corp. are
available to download free of charge at:
http://www.AnalystsReview.com/04072014/LMCA/report.pdf
--
Apollo Education Group Inc. Analyst Notes
On April 1, 2014, Apollo Education
Group Inc. (Apollo Education) released its Q2 FY 2014 results
(period ended February 28, 2014). The
Company reported net revenue of $679.1
million in Q2 FY 2014, down 18.6% YoY. During the quarter,
the Company's net revenue from University of
Phoenix declined 21.2% YoY to $594.1
million. The Company's net income attributable to Apollo
Education came in at $14.6 million or
$0.13 per diluted share in Q2 FY
2014, compared to a net income of $13.5
million or $0.12 per diluted
share in Q2 FY 2013. Going forward, the Company expects net revenue
in the range of $3.0 billion - $3.1
billion and operating income of $400
million - $450 million, excluding the impact of special
items for full year FY 2014. The full analyst notes on Apollo
Education Group Inc. are available to download free of charge
at:
http://www.AnalystsReview.com/04072014/APOL/report.pdf
--
Yum! Brands Inc. Analyst Notes
On March 31, 2014, Yum! Brands
Inc. (Yum!) announced the release of its online 2013 Corporate
Social Responsibility (CSR) Report. According to the Company, the
CSR report emphasizes on the efforts of the Company in relation to
its four strategic areas of focus: Food, People, Community, and
Environment. The report features success stories of Yum! in
interactive, info-graphic-style and video formats. The stories and
examples in the report are mainly related to the global view of the
Company and its CSR efforts, including its philanthropic cause,
World Hunger Relief, which has become the world's largest private
sector hunger relief effort, in support of the United Nations World
Food Programme and other hunger relief agencies. Further, the
Company has also declared the month of April as the CSR month. The
full analyst notes on Yum! Brands Inc. are available to download
free of charge at:
http://www.AnalystsReview.com/04072014/YUM/report.pdf
--
Myriad Genetics Inc. Analyst Notes
On April 2, 2014, shares in Myriad
Genetics Inc. (Myriad) rallied 11.47% to end the trading session at
$39.18 on high volumes. Myriad's
share price got a boost from the Company's announcement that the
Centers for Medicare and Medicaid Services (CMS) will pay
$2,767 for the Company's gene-based
tests for breast cancer, 37% more than the $2,021 CMS was paying for the tests. A total of
7.50 million shares were traded, which was significantly above its
30-day average volume of 2.14 million. Over the past one month, the
stock has gained 7.98% outperforming the NASDAQ Composite which
lost 0.64% over the same period. The full analyst notes on Myriad
Genetics Inc. are available to download free of charge at:
http://www.AnalystsReview.com/04072014/MYGN/report.pdf
--
About Analysts Review
We provide our members with a simple and reliable way to leverage
our economy of scale. Most investors do not have time to track all
publicly traded companies, much less perform an in-depth review and
analysis of the complexities contained in each situation. That's
where Analysts Review comes in. We provide a single unified
platform for investors' to hear about what matters. Situation
alerts, moving events, and upcoming opportunities.
--
=============
EDITOR NOTES:
- This is not company news. We are an independent source and our
views do not reflect the companies mentioned.
- Information in this release is fact checked and produced on a
best efforts basis and reviewed by Ananya
Ghosh, a CFA charterholder. However, we are only human and
are prone to make mistakes. If you notice any errors or omissions,
please notify us below.
- This information is submitted as a net-positive to companies
mentioned, to increase awareness for mentioned companies to our
subscriber base and the investing public.
- If you wish to have your company covered in more detail by our
team, or wish to learn more about our services, please contact us
at pubco [at] AnalystsReview.com.
- For any urgent concerns or inquiries, please contact us
at compliance [at] AnalystsReview.com.
- Are you a public company? Would you like to see similar
coverage on your company? Send us a full investors' package to
research [at] AnalystsReview.com for consideration.
COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort
basis. This document, article or report is prepared and authored by
Analysts Review. An outsourced research services provider
represented by Ananya Ghosh, CFA,
has only reviewed the information provided by Analysts Review in
this article or report according to the Procedures outlined by
Analysts Review. Analysts Review is not entitled to veto or
interfere in the application of such procedures by the outsourced
provider to the articles, documents or reports, as the case may
be.
NOT FINANCIAL ADVICE
Analysts Review makes no warranty, expressed or implied, as to
the accuracy or completeness or fitness for a purpose (investment
or otherwise), of the information provided in this document. This
information is not to be construed as personal financial advice.
Readers are encouraged to consult their personal financial advisor
before making any decisions to buy, sell or hold any securities
mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Analysts Review is not responsible for any error which may be
occasioned at the time of printing of this document or any error,
mistake or shortcoming. No liability is accepted by Analysts Review
whatsoever for any direct, indirect or consequential loss arising
from the use of this document. Analysts Review expressly disclaims
any fiduciary responsibility or liability for any consequences,
financial or otherwise arising from any reliance placed on the
information in this document. Analysts Review does not (1)
guarantee the accuracy, timeliness, completeness or correct
sequencing of the information, or (2) warrant any results from use
of the information. The included information is subject to change
without notice.
CFA® and Chartered Financial Analyst® are registered trademarks
owned by CFA Institute.
SOURCE Analysts Review